Banyan Biomarkers

Banyan Biomarkers is developing the first objective blood test that may rule out the need for CT scans in patients with suspected mild traumatic brain injury.

[Banyan Biomarkers @banyanbio]

Banyan Biomarkers wishes you a Happy New Year! #biotech #biomedicine #SanDiego #innovation

[Banyan Biomarkers @banyanbio]

Happy Holidays from the Banyan team ❄️ may your days be merry and bright! #SanDiego #biotech

[Banyan Biomarkers @banyanbio]

Capping off a great 2018, Banyan’s BTI test for traumatic brain injury has earned a spot on @CONNECTinSD’s annual list of “most innovative” products. Check out @Xconomy’s coverage of all 7 winners here: https://t.co/aYo2fqj6nX #CONNECTMIP #diagnostics #TBI

[Banyan Biomarkers @banyanbio]

Banyan Biomarkers Receives Contract by U.S. Department of Defense for Banyan BTI™

#TraumaticBrainInjury #Concussion #TBI #SanDiego #biotech

https://t.co/tsT4uHN9BM

[Banyan Biomarkers @banyanbio]

Thanks @connectinsd for recognizing Banyan BTI™ as a finalist for the Most Innovative New Product Award in the Life Science Diagnostic category.

https://t.co/DGX35lEKTm

#SanDiego #diagnostics #lifesciences #innovation #TBI

[Banyan Biomarkers @banyanbio]

Banyan Biomarkers Announces Publication of ALERT-TBI Clinical Study Results in @TheLancetNeuro

https://t.co/30cC64eyWb

#TraumaticBrainInjury #Concussion

[Banyan Biomarkers @banyanbio]

FDA Grants Marketing Authorization to Banyan Biomarkers for the First Diagnostic Blood Test for #TraumaticBrainInjury https://t.co/ABQJrgk02A
#TBI #Concussion